Paper8538705
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
Gustafsson L and 4 others. N Engl J Med, 1996. Cited by 607 papers, by iCite.
Cite this record
ConductScience Library. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Papers, record 8538705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8538705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pertussis Vaccine | Major topic |
| Whooping Cough | Major topic |
| Antibodies, Bacterial | |
| Antigens, Bacterial | |
| Bordetella pertussis | |
| Diphtheria Toxoid | |
| Diphtheria-Tetanus Vaccine | |
| Diphtheria-Tetanus-Pertussis Vaccine | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Immunoglobulin G | |
| Infant | |
| Male | |
| Tetanus Toxoid | |
| Treatment Outcome | |
| Vaccines, Combined | |
| Vaccines, Inactivated | |
| Virulence Factors, Bordetella |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N01-AI-15125 | NIAID NIH HHS | United States | N01AI015125 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 8538712 | Acellular pertussis vaccines for infants. | https://conductscience.org/library/papers/8538712 |
Source PubMed
Cited by193
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 607 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797595 | Whole-Cell and Acellular Pertussis Vaccines: A Narrative Review of Biological, Clinical, Safety and Programmatic Evidence, with Implications for Poland. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797595 | PubMed |
| 42477039 | Post-exposure booster vaccination recalls vaccine-induced memory and accelerates Bordetella pertussis clearance in murine lungs and trachea. | Sci Rep | 2026 | https://conductscience.org/library/papers/42477039 | PubMed |
| 42437472 | Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review. | Acta Paediatr | 2026 | https://conductscience.org/library/papers/42437472 | PubMed |
| 42347613 | Development of High-Throughput Serum Bactericidal Assays for Bordetella pertussis to Evaluate BPZE1. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347613 | PubMed |
| 42060701 | SeaB is a conserved Salmonella enterica extracellular matrix binding protein involved in biofilm formation and infection. | Infect Immun | 2026 | https://conductscience.org/library/papers/42060701 | PubMed |
| 41770752 | Comparative analysis of the diversity within the B. bronchiseptica fimX locus. | PLoS One | 2026 | https://conductscience.org/library/papers/41770752 | PubMed |
| 41214155 | Respiratory immunization using antibiotic-inactivated Bordetella pertussis confers T cell-mediated protection against nasal infection in mice. | Nat Microbiol | 2025 | https://conductscience.org/library/papers/41214155 | PubMed |
| 40842393 | Resurgence of pertussis: whopping the '100-day cough'. | Curr Opin Pediatr | 2025 | https://conductscience.org/library/papers/40842393 | PubMed |
| 40689608 | Variation in virulence between three representative Bordetella pertussis pertactin-negative clinical isolates. | mSphere | 2025 | https://conductscience.org/library/papers/40689608 | PubMed |
| 40540779 | Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel. | Vaccine | 2025 | https://conductscience.org/library/papers/40540779 | PubMed |
| 39684849 | Current Progress in the Development of mRNA Vaccines Against Bacterial Infections. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684849 | PubMed |
| 39669568 | Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection. | Front Immunol | 2024 | https://conductscience.org/library/papers/39669568 | PubMed |
| 39565788 | High pertussis circulation among infants, children and adolescents in Abidjan, Côte d'Ivoire. | PLoS One | 2024 | https://conductscience.org/library/papers/39565788 | PubMed |
| 39441011 | A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challenge. | mSphere | 2024 | https://conductscience.org/library/papers/39441011 | PubMed |
| 39417957 | Bibliometrics analysis and knowledge mapping of pertussis vaccine research: trends from 1994 to 2023. | Infection | 2025 | https://conductscience.org/library/papers/39417957 | PubMed |
| 39218947 | Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/39218947 | PubMed |
| 39205626 | The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer. | Hum Vaccin Immunother | 2024 | https://conductscience.org/library/papers/39205626 | PubMed |
| 38857311 | Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. | PLoS Med | 2024 | https://conductscience.org/library/papers/38857311 | PubMed |
| 38752005 | Safety assessments of recombinant DTaP vaccines developed in South Korea. | Clin Exp Vaccine Res | 2024 | https://conductscience.org/library/papers/38752005 | PubMed |
| 37565807 | Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model. | J Infect Dis | 2024 | https://conductscience.org/library/papers/37565807 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8538705
GET https://conductscience.org/api/papers/v1/8538705/cited_by?page=2